+ Watch ENZ
on My Watchlist
The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.
Enzo may have been awarded 49M in a patent infringement suit against Life Technologies, but that cash isn't in the bank yet. Aside from appeals and other machinations that may delay Enzo's receipt of the award, Enzo still has static revenues and negative cash flow. The stock has had a nice comeback from last summer's lows around 1.5 but I think it's getting a little ahead of itself over 3.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions